Therapeutic Targeting of Lipid Nanoparticles
US-2024131181-A1 · Apr 25, 2024 · US
US9358310B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9358310-B2 |
| Application number | US-201213668916-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 5, 2012 |
| Priority date | Sep 17, 2007 |
| Publication date | Jun 7, 2016 |
| Grant date | Jun 7, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from epigallocatechin Gallate (EGCg), which is a polyphenols- or flavonoids-rich plant material that can be obtained from green tea. The EGCg is an antioxidant reducing agent derived from green tea. The gold nanoparticles of the invention can be radioactive or non radioactive and are formed via a simple room temperature fabrication method. In preferred embodiment method of making, an aqueous solution containing gold salts is provided. The aqueous solution is mixed with EGCg in a buffer, such as deionized water. The gold salts react to form biocompatible gold nanoparticles that are stabilized with a coating of EGCg. The thermodynamically feasible redox couple of AuCl4-/EGCg leading to the reduction of AuCl4- by EGCg to form gold nanoparticles. In another embodiment, pre-cooled gold salt and EGCg solutions form multi-layered EGCg coated particles.
Opening claim text (preview).
The invention claimed is: 1. An environmentally friendly method for making epigallocatechin Gallate (EGCg) stabilized gold nanoparticles, the method comprising: mixing a solution of epigallocatechin Gallate (EGCg) as a reducing agent with an aqueous solution containing gold salts; permitting reaction of the gold salts, in the absence of any other reducing agent, to form stabilized, biocompatible gold nanoparticles. 2. The method of claim 1 , wherein the solution containing gold salts comprises AuCl 4 . 3. The method of claim 2 , wherein the solution of EGCg comprises deionized water. 4. The method of claim 3 , wherein the solution of gold salts comprises carrier NaAuCl 4 solution. 5. The method of claim 4 , wherein the carrier NaAuCl 4 solution is adjusted to a neutral pH and isotonic. 6. The method of claim 1 , wherein the solution of gold salts comprises H 198 AuCl 4 . 7. The method of claim 6 , wherein the solution of EGCg comprises deionized water. 8. The method of claim 7 , wherein the solution of gold salts further comprises a carrier NaAuCl 4 solution. 9. The method of claim 8 , wherein the carrier NaAuCl 4 solution is adjusted to a neutral pH and isotonic. 10. The method of claim 1 , further comprising a step of heating the aqueous solution during said step of permitting reaction. 11. The method of claim 10 , wherein said step of heating comprises microwave heating. 12. The method of claim 1 , further comprising a step of adjusting the pH of the aqueous solution after said step of permitting reaction. 13. The method of claim 1 , further comprising a step of adding a stabilizing agent to the aqueous solution after said step of permitting reaction. 14. The method of claim 13 , wherein said stabilizing agent comprises gum Arabic. 15. The method of claim 1 , wherein the gold salts comprises either sodium tetrachloaurate or aurochloric acid. 16. The method of claim 1 , wherein the solution containing gold salts and the solution of EGCg are pre-cooled below room-temperature prior to said mixing. 17. The method of claim 16 , wherein the solution containing gold salts and the solution of EGCg are pre-cooled to ˜4° C. and equilibrated.
Antineoplastic agents · CPC title
Medicinal preparations obtained by treating materials with wave energy or particle radiation {; Therapies using these preparations} · CPC title
microparticles or nanoparticles, e.g. polymeric nanoparticles · CPC title
micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules · CPC title
with compounds of unknown constitution, e.g. material from plants or animals (with oils, fats, waxes, shellac A61K9/145) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.